“Further, we presented results of our ongoing studies at major conferences, including our Phase III ExteNET study at the European Society for Medical Oncology 2017 Congress, our Phase II CONTROL study at the 2017 San Antonio Breast Cancer Symposium, and our Phase II SUMMIT study at the…
News
- Puma Biotechnology Reports Fourth Quarter and Full Year 2017 Financial Results
- SA biotech gets access to cancer institute's research network — and a wider audience
San Antonio-based bioAffinity Technologies has been approved for membership in the Early Detection Research Network, an initiative of the National Cancer Institute. The approval gives the privately held biotech — which is advancing commercialization of its first product, a lung cancer diagnostic…
- COBRA PzF NanoCoated Coronary Stent (NCS) to be Highlighted at CRT 2018 Meeting
SAN ANTONIO, Texas, Feb. 28, 2018 /PRNewswire/ -- CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced the upcoming educational events to take place…
- A marijuana startup is listing on a major US stock exchange for the first time — here's what you ...
Cronos Group will become the first marijuana company to trade on a major US stock exchange. The company owns and operates businesses that are licensed to grow and sell weed in Canada, where medical marijuana is legal. The listing could signal to governments and investors that the legal…
- A fertility doctor's secret, a special kinship decades later
She took a DNA test from 23andMe, a biotech company that uses saliva samples to determine ancestry and identify distant and close relatives, health risks and physical traits. Ballard's results listed seven half-siblings. She and two others assembled a family tree and realized their mothers had…